Abstract
This 2026 update integrates emerging trial evidence — particularly for weight loss and liver disease — to refine EASO’s treatment algorithm for obesity management.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Nature Medicine |
| Vol/bind | 32 |
| Udgave nummer | 6 |
| Sider (fra-til) | 1962-1966 |
| Antal sider | 5 |
| ISSN | 1078-8956 |
| DOI |
|
| Status | Udgivet - jun. 2026 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO): 2026 update'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS